Kyowa Kirin and MEI Pharma report data from Phase II lymphoma trial
Hematological Disorders
TC BioPharm doses first subjects in Phase IIb leukaemia trial
On dosing five patients in the trial, the study will progress to open enrolment.
Bio-Path doses first subject in Phase I/Ib acute myeloid leukaemia trial
X4 Pharma previews Phase III trial plans in rare blood disorder
BMS and ConcertAI launch digital trial solution for oncology
Ichnos doses first subject in Phase I/II trial of R/R MM treatment
I-Mab reports positive data from Phase II myelodysplastic syndrome trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
